Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Related studies linked through entity extraction aliases.